 The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to effectively treat acute kidney injury AKI in pediatric patients by reducing blood urea nitrogen BUN. 